The association of baseline N-terminal pro-B-type natriuretic peptide with short and long-term prognosis following percutaneous coronary intervention in non-ST segment elevation acute coronary syndrome with multivessel coronary artery disease: a retrospective cohort study

Associations between depression, resilience, and fatigue in patients with multivessel coronary disease: A cross-lag study

Objectives

This study aimed to examine the associations between depression, resilience, and fatigue in patients with multivessel coronary disease and verify their causal relationships.

Methods

Between October 2023 and June 2024, 316 patients with multivessel coronary disease were recruited from three tertiary hospitals in Tangshan, China. The Patient Health Questionnaire, Connor-Davidson Resilience Scale, and the Multidimensional Fatigue Inventory were administered to the patients on the third day of admission (T1), one month after discharge (T2), and three months after discharge (T3). Pearson correlation analysis was conducted to examine the relationships among depression, resilience, and fatigue in patients with multivessel coronary disease, and cross-lagged analysis to explore the temporal causal relationships.

Results

In patients with multivessel coronary disease, levels of depression and fatigue decreased from T1 to T3, while resilience scores increased during the same period. The correlation analysis revealed significant relationships among depression, resilience, and fatigue at T1, T2, and T3 (P < 0.01). The autoregressive paths indicated high stability over time for depression, medium stability for resilience, and low stability for fatigue. Cross-lagged paths demonstrated that depression at T1 significantly predicted fatigue at T2 (β = 0.461, P < 0.001), and depression at T2 significantly predicted fatigue at T3 (β = 0.957, P < 0.001). And resilience at T1 significantly predicted fatigue at T2 (β = -0.271, P < 0.001), and resilience at T2 significantly predicted fatigue at T3 (β = -0.176, P < 0.001). Additionally, resilience had a moderating effect on the relationship between depression and fatigue (β = -0.760, P < 0.001).

Conclusions

Our study confirmed that depression and resilience predicted fatigue in patients with multivessel coronary disease. To prevent and mitigate fatigue, alleviating depressive symptoms and enhancing resilience levels in patients at an early stage is essential.

Correlation of blood lipids, glucose, and inflammatory indices with the occurrence and prognosis of lesion complexity in unstable angina, a retrospective cohort study

Background

In recent years, novel cardiometabolic biomarkers and related pathogenic genes and their heritability have been examined. However, no multitarget predictive evaluation models exist can identify and predict complex lesions in unstable angina (UA) in the early stages before coronary angiography (CAG) or evaluate the prognosis of patients with UA and complex lesions. In this study, we sought to investigate the correlation between blood lipid, glucose, and inflammatory indices and the occurrence and prognosis of UA with complex lesions, and also the risk factors for major adverse cardiocerebrovascular events (MACCEs).

Methods

Patients with UA who underwent percutaneous coronary intervention (PCI) at Chaoyang Hospital between March 2019 and December 2020 were included. Patients with UA who underwent PCI were divided into complex lesion group and noncomplex lesion group according to the CAG results. The blood lipid and glucose levels, inflammatory indices, Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery (SYNTAX) scores, and clinical outcome events after 3 years follow-up from both groups were calculated.

Results

A total of 523 patients were included, with 248 and 275 patients in the complex and noncomplex lesion groups, respectively. There were no significant differences between the two groups in terms of sex, age, medical history, or demographic characteristics. After 3 years of follow-up, compared with the noncomplex lesion group, the complex lesion group had a higher incidence of target vessel revascularization (TVR) (8.1% vs. 4.0%; P=0.049) and MACCEs (11.7% vs. 5.8%; P=0.02). High remnant lipoprotein cholesterol (RLP-C) level, high small dense low-density lipoprotein cholesterol (sLDL-C) level, high lipoprotein (a) [Lp(a)] level, high high-sensitivity C-reactive protein (hs-CRP) level, low lymphocyte level, low albumin level, and low hs-CRP:albumin ratio (CAR) were found to be risk factors for the occurrence of UA with complex lesions. High RLP-C level, high sLDL-C level, high Lp(a) level, and high neutrophil:lymphocyte ratio (NLR) were independent risk factors for MACCEs in the complex lesion group, from which a new prediction model was created. The area under the curve (AUC) of the new model for predicting MACCEs events after 3 years of follow-up [AUC =0.935; 95% confidence interval (CI): 0.881-0.989] in the complex lesion group was higher than that of the SYNTAX score (AUC =0.671; 95% CI: 0.584-0.757) (P<0.001).

Conclusions

Blood lipid and glucose levels and inflammatory indices may be associated with the occurrence of UA with complex lesions. The new model for UA with complex lesions constructed using high RLP-C level, high sLDL-C level, high Lp(a) level, and high NLR level had a stronger ability to predicts MACCEs during follow-up than did the SYNTAX score. Our findings could enhance early detection of patients with UA and complex lesions, potentially improving prevention and treatment strategies for perioperative UA-PCI patients.

Impact of treatment management on the hospital stay in patients with acute coronary syndrome

BACKGROUND

The length of hospital stay in patients with acute coronary syndrome (ACS) is crucial for determining clinical outcomes, managing healthcare resources, controlling costs, and ensuring patient well-being. This study aimed to explore the impact of treatment approaches on the length of stay (LOS) for ACS patients.

METHODS

A total of 7109 ACS cases were retrospectively recruited from a hospital between 2018 and 2023. Demographical baseline data, laboratory examinations, and diagnostic and treatment information of the included subjects were extracted from electronic medical records to investigate the factors contributing to extended hospitalization and further explore the impact of treatment management on the LOS.

RESULTS

Advanced age, female sex, and elevated levels of B-type natriuretic peptide, C-reactive protein and higher low-density lipoprotein cholesterol were identified as risk factors for extended hospitalization. At the 0.2-0.9 quantile of LOS, compared with the non-invasive group, the percutaneous transluminal coronary angioplasty group and the stent implantation group exhibited decreases in LOS of 0.37-2.37 days and 0.12-2.28 days, respectively. Stratified analysis based on diagnosis showed that percutaneous coronary intervention decreased hospitalization time in the high quantile of LOS but conversely increased it in the low quantile.

CONCLUSION

Percutaneous coronary intervention is important for reducing hospitalization duration, particularly for patients susceptible to prolonged stays. Early and assertive management intervention, incorporating elements such as lipid-lowering therapy, and anti-inflammatory agents, is essential for improving outcomes within high-risk groups.

Relationship between NT-proBNP levels and existing/de novo QRS fragmentation in patients with myocardial infarction

Aim: to assess the evolution of fragmented QRS (fQRS) and NT-proBNP levels during myocardial infarction (MI).Methods: Among 511 patients, 205 (40.1%) had fQRS, with 54 (26.3%) developing de novo fragmentation during hospitalization.Results: NT-proBNP levels were significantly higher in the fQRS+ group compared with the fQRS- group (1555 vs. 796 pg/ml, p < 0.001). NT-proBNP levels were higher in patients with de novo fragmentation than in those without (2852 vs. 1370 pg/ml, p = 0.011). The incidence of major adverse cardiovascular events was notably higher in fQRS+ patients compared with fQRS- patients (p = 0.001).Conclusion: In acute MI, there was a significant association between fQRS and NT-proBNP levels, with higher NT-proBNP levels observed in those with de novo fQRS compared with those without.

The joint association of diabetes status and NT-ProBNP with adverse cardiac outcomes in patients with non-ST-segment elevation acute coronary syndrome: a prospective cohort study

AIMS

To examine the joint association of diabetes status and N-terminal pro-B-type natriuretic peptide (NT-proBNP) with subsequent risk of major adverse cardio-cerebral events (MACCEs) and all-cause mortality in patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS).

METHODS

A total of 7956 NSTE-ACS patients recruited from the Cardiovascular Center Beijing Friendship Hospital Database Bank were included in this cohort study. Patients were divided into nine groups according to diabetes status (normoglycemia, prediabetes, diabetes) and NT-proBNP tertiles (< 92 pg/ml, 92-335 pg/ml, ≥ 336 pg/ml). Multivariable Cox proportional hazards models were used to estimate the individual and joint association of diabetes status and NT-proBNP with the risk of MACCEs and all-cause mortality.

RESULTS

During 20,257.9 person-years of follow-up, 1070 MACCEs were documented. In the fully adjusted model, diabetes and a higher level of NT-proBNP were independently associated with MACCEs risk (HR 1.42, 95% CI: 1.20-1.68; HR 1.72, 95% CI: 1.40-2.11) and all-cause mortality (HR 1.37, 95% CI: 1.05-1.78; HR 2.80, 95% CI: 1.89-4.17). Compared with patients with normoglycemia and NT-proBNP < 92 pg/ml, the strongest numerical adjusted hazards for MACCEs and all-cause mortality were observed in patients with diabetes and NT-proBNP ≥ 336 pg/ml (HR 2.67, 95% CI: 1.83-3.89; HR 2.98, 95% CI: 1.48-6.00). The association between MACCEs and all-cause mortality with various combinations of NT-proBNP level, HbA1c, and fasting plasma glucose was studied.

CONCLUSIONS

Diabetes status and elevated NT-proBNP were independently and jointly associated with MACCEs and all-cause mortality in patients with NSTE-ACS.

Brain natriuretic peptide as a biomarker for predicting contrast-induced nephropathy in patients undergoing coronary angiography/intervention: A systematic review and meta-analysis

BACKGROUND

Contrast-induced nephropathy (CIN) is associated with adverse events. As there are no effective treatments, the early identification of high-risk patients is required. Individual studies have suggested the utility of brain natriuretic peptide in predicting CIN. Therefore, this meta-analysis aimed to systematically investigate the value of brain natriuretic peptide in predicting CIN in patients undergoing coronary angiography (CAG) or percutaneous coronary intervention (PCI).

METHODS

We searched PubMed, Embase, Cochrane Central Register of Controlled Trials Library, and Web of Science from inception date to March 9, 2022. Studies that evaluated the predictive value of brain natriuretic peptide for CIN outcomes in patients after CAG or PCI were included. The quality of the included studies was assessed using the QUADAS-2 tool. Diagnostic accuracy estimates were calculated using a random-effects model. Subgroup and meta-regression analyses were performed to identify the potential sources of heterogeneity.

RESULTS

Twelve studies with 7789 patients were included in the meta-analysis. The pooled sensitivity and specificity of brain natriuretic peptide for the prediction of CIN were 0.73 (95% CI: 0.67-0.78) and 0.77 (95% CI: 0.71-0.82), respectively. The area under the summary receiver operating characteristic curve was 0.80 (95% CI: 0.77-0.84). Meta-regression analysis indicated that the sources of sensitivity heterogeneity may be the country, mean age, and study population. Additionally, country, study population, study design, and index text contributed to the specificity heterogeneity.

CONCLUSION

This study demonstrated that brain natriuretic peptide could function as a novel potential marker for the early detection of CIN in patients undergoing CAG or PCI.

Association of N-terminal pro-B-type natriuretic peptide with mortality in elderly (≥80 years) patients undergoing percutaneous coronary intervention

OBJECTIVES

The aim of this study was to determine the role of N-terminal pro-B-type natriuretic peptide (NT-proBNP) in the prognostication of patients ≥80 years of age undergoing percutaneous coronary intervention (PCI).

BACKGROUND

Elderly patients with coronary artery disease in need of PCI represent a growing patient population. Advanced risk prediction in this frail and comorbid patient population is important.

METHODS

A total of 460 consecutive patients ≥80 years of age undergoing PCI for acute (ACS) or chronic coronary syndromes (CCS) at the University Hospital Zurich, Switzerland, between January 2016 and December 2018 and with available baseline NT-proBNP levels were included in the analysis. Patients were stratified according to baseline NT-proBNP levels. The primary endpoint was all-cause mortality at a median follow-up of 33 (interquartile range: 3-392) days.

RESULTS

Median baseline NT-proBNP levels were 1411 (457-3984) ng/L. All-cause mortality was 7.8% in the lowest and 27.8% in the highest NT-proBNP quartile group (p < 0.001). In patients with ACS, all-cause mortality was 4.8% and 30.4% in the lowest and the highest NT-proBNP quartile (p < 0.001), and corresponding rates in patients with CCS were 11.1% and 22.2% (p = 0.38). In multivariable Cox regression analysis, baseline NT-proBNP levels were independently associated with an increased risk of all-cause mortality (adjusted hazard ratio: 1.00, 95% confidence interval: 1.00-1.00, p = 0.04).

CONCLUSIONS

Baseline NT-proBNP levels were identified as independent predictor of mortality in elderly (≥80 years) patients undergoing PCI. Hence, baseline NT-proBNP allows for the identification of a high-risk elderly patient subset.

The Relationship between Selected Inflammation and Oxidative Stress Biomarkers and Carotid Intima-Media Thickness (IMT) Value in Youth with Type 1 Diabetes Co-Existing with Early Microvascular Complications

Recent years have confirmed the importance of oxidative stress and biomarkers of inflammation in estimating the risk of cardiovascular disease (CVD) and explaining not fully understood pathogenesis of diabetic macroangiopathy. We aimed to analyze the relation between the intima-media thickness (IMT) of common carotid arteries and the occurrence of classical cardiovascular risk factors, together with the newly proposed biomarkers of CVD risk (high-sensitivity C-reactive protein (hsCRP), myeloperoxidase (MPO), adiponectin, N-terminal-pro B-type natriuretic peptide (NT-proBNP) and vitamin D) in youth with type 1 diabetes (T1D) recognized in screening tests to present early stages of microvascular complications (VC). The study group consisted of 50 adolescents and young adults with T1D, mean age 17.1 years (10–26 age range), including 20 patients with VC (+) and 30 VC (−). The control group (Control) consisted of 22 healthy volunteers, mean age 16.5 years (11–26 age range). In the VC (+) patients, we found a significantly higher concentration of HbA1c, lipid levels, hsCRP and NT-proBNP. BMI and blood pressure values were highest in the VC (+) group. Higher levels of MPO and lower levels of vitamin D were found in both diabetic groups vs. Control. IMT in VC (+) patients was significantly higher and correlated positively with HbA1c, hsCRP, NT-pro-BNP and negatively with vitamin D levels. In conclusion, youth with T1D and VC (+) present many abnormalities in the classical and new CVD biomarkers. hsCRP and MPO seem to be the most important markers for estimating the risk of macroangiopathy. NT-proBNP may present a possible marker of early myocardial injury in this population.